Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway

Non-small cell lung cancer (NSCLC) is a prominent subtype of lung carcinoma that accounts for the majority of cancer-related deaths globally, and it is responsible for about 80% to 85% of lung cancers. Mitogen-Activated Protein Kinase (MAPK) signaling pathways are a vital aspect of NSCLC, and have a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Anisha S., Prasad, Ashwini, Pradeep, Sushma, Dharmashekar, Chandan, Achar, Raghu Ram, Silina, Ekaterina, Stupin, Victor, Amachawadi, Raghavendra G., Prasad, Shashanka K., Pruthvish, R, Syed, Asad, Shivamallu, Chandan, Kollur, Shiva Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526962/
https://www.ncbi.nlm.nih.gov/pubmed/34692523
http://dx.doi.org/10.3389/fonc.2021.741326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526962/
https://www.ncbi.nlm.nih.gov/pubmed/34692523
http://dx.doi.org/10.3389/fonc.2021.741326

Ejemplares similares